A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double-blind, placebo-controlled study is to assess the
safety and efficacy of PRX-00023 in patients with major depressive disorder.